Advertisement
Home Authors Posts by HealthDay.com

HealthDay.com

HealthDay.com
38592 POSTS 0 COMMENTS
U.S. Food and Drug Administration approval of the drug Promacta (eltrombopag) has been expanded to include children 1 year and older with chronic immune thrombocytopenic purpura.

Promacta Approval Expanded for Children With Chronic ITP

0
Builds on recent approval for ages 6 years and up for chronic immune thrombocytopenic purpura
Children are receiving fewer computed tomography scans now than a decade ago

Pediatric CT Scan Use Has Declined Over Past Decade

0
More children are undergoing MRI scans and ultrasounds, which don't carry radiation risks
High temperatures lead to increased emergency department visits and mortality

Experts Warn Climate Change Will Bring More ER Visits, Mortality

0
Strongest link between temperatures and heat-related hospital visits is among 18- to 64-year-olds
New mothers may inadvertently pass industrial chemicals along to their infants through breastfeeding

Perfluorinated Alkylate Levels Up in Breastfed Infants

0
And PFASs appear to lower effectiveness of some childhood vaccinations, researchers add
Weight loss can improve nonalcoholic steatohepatitis in obese or overweight people

Weight Loss Benefits NASH, No Matter How It’s Done

0
Through surgery or lifestyle changes, weight loss improves nonalcoholic steatohepatitis
Weight loss is more successful for obese patients who feel they have the most helpful doctors compared to those who feel their doctors are less helpful

Supportive Doctors Boost Patients’ Weight-Loss Efforts

0
Researcher suggests including physicians in commercial programs
In 2001 to 2010

Ureteric Injury Risk With Hysterectomy Up 2001 to 2010

0
Risk varies by type of hysterectomy for benign and malignant conditions; lower for benign conditions
Metformin may act via a predominantly lower bowel-mediated mechanism

Metformin Effects May Be Via Gut, Not Bloodstream

0
Dissociation of glycemic effect from plasma exposure with gut-restricted metformin
Nonselective beta-blocker use is associated with improved overall survival among patients with epithelial ovarian

Nonselective Beta-Blocker Use Ups Survival in Ovarian Cancers

0
Longer median overall survival for patients receiving any beta-blocker versus nonusers
Pulsed dye laser therapy seems feasible for treating steroid-induced atrophic scars

Pulsed Dye Laser Feasible for Steroid-Induced Atrophic Scars

0
Of 15 patients treated with pulsed dye laser, all but one experienced some degree of improvement